A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease
Clinical trial NCT04929210 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04929210
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-30
- Primary completion
- 2026-08-04
- Enrollment
- 411
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.